REFERENCES
- Alexander A.M., Gonda I., Harpur E.S., Kayes J.B. (1979) J. Antibiot. (Tokyo), 32, 504–510
- Aramaki Y., Tsuchiya S. (1989) Pharm. Res., 6, 362–366
- Bates D.E., Beaumont S.J., Baylis B.W. (2002) The Annals of Pharmacotherapy, 36, 446–451
- Bennett W.M., Clayton W., Houghton D.C., Gilbert D.N. (1982) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 508–512
- Christova Y., Enchev E., Lalchev Z. (1998) Eur. Biophys. J., 28, 59–66
- Chung L., Kaloyanides G., Mcdaniel R., Mclaughlin A., Mclaughlin S. (1985) Biochemistry, 24, 442–452
- Dominguez J.H., Hale C.C., (1996) Qulali M. Am. J. Physiol., 270, 245–53
- East J. E., Fowarake J. E., (2005) Murgatroyd F. D. Heart, 91:e32
- Forge A., Zajic G., Davies S., Weiner N., Schacht J. (1989) Hear Res., 37, 129–139
- Georgiev G., Lalchev Z. (2004) Eur. Biophys. J., 33, 742–748
- Kornguth V., Bayer W. H., Kunin C. M. (1980) J. Antimicrob. Chemother., 6, 121–131
- Kubo M., Gardner M.F., Hostetler K.Y. (1986) Biochem. Pharmacol., 35, 3761–3765
- Rougler F., Claude F., Maurin D., Maire P. (2004) Curr Drug Targets Infect. Disord., 4, 153–62
- Scand D.K. (1980) J. Infect. Dis. Suppl., 36, 46–53.
- Smaby, J.M., Kulkarni V.S., Momsen M., Brown RE. (1996) Biophys. J., 70, 868–877